Article

A Polymorphism of the ??-Opioid Receptor Gene (OPRM1) and Sensitivity to the Effects of Alcohol in Humans

University of Colorado, Boulder, CO 80309-0345, USA.
Alcoholism Clinical and Experimental Research (Impact Factor: 3.31). 01/2005; 28(12):1789-95. DOI: 10.1097/01.ALC.0000148114.34000.B9
Source: PubMed

ABSTRACT Recent research has implicated the endogenous opioid system in the development of alcohol use disorders. The A118G polymorphism of the OPRM1 gene has been shown to confer functional differences to mu-opioid receptors, such that the G variant binds beta-endorphin three times more strongly than the A variant. The goal of this study was to test whether the A118G polymorphism is associated with sensitivity to the effects of alcohol.
Participants who were either homozygous for the A allele (n = 23) or heterozygous (n = 15) received intravenous doses of alcohol designed to reach three target levels of breath alcohol concentration: 0.02, 0.04, and 0.06. The testing procedure consisted of measures of subjective intoxication, stimulation, sedation, and mood states at baseline and at each of the three target breath alcohol concentrations.
The results suggested that individuals with the G allele reported higher subjective feelings of intoxication, stimulation, sedation, and happiness across trials as compared with participants with the A allele. Furthermore, participants with the G allele were almost three times more likely to report a positive family history of alcohol use disorders than participants with the A allele.
These findings may help to explain previous research suggesting that naltrexone is more effective among individuals with the G allele. A medication that reduces feelings of euphoria after alcohol consumption may be more successful among individuals with a genetic predisposition to greater feelings of euphoria after consuming alcohol.

0 Followers
 · 
102 Views
  • Source
    • "The OPRM1 gene encodes for the µ-opioid receptor (MOR, receptor of endogenous opioids including heroin, morphine, and methadone). The OPRM1 polymorphism consists of an adenine to guanine substitution which affects the reinforcing (thus addictive) effect of drugs in various brain regions ( Ray et al., 2011) This polymorphism has been linked to a variety of substance use characteristics including sensitivity to the effects of alcohol (Ray & Hutchison, 2004) and adolescent alcohol misuse (Miranda et al., 2010), heroin addiction (Shi et al., 2002), and nicotine reinforcement ( Ray et al., 2006). OPRM1 has also been associated with neural sensitivity to social rejection (Way, Taylor, & Eisenberger, 2009). "
    Handbook of biosocial criminology, Edited by Matt DeLisi, Matthew G. Vaughn, 01/2015: pages 101-114; Routledge.
  • Source
    • "An experimental study focusing on behavioral mechanisms of alcohol reward in a sample of heavy drinkers has shown that compared with A-allele homozygotes, G-allele carriers report greater subjective reinforcement from alcohol in the laboratory (Ray and Hutchison, 2004). Similar results were obtained in a naturalistic study of the effects of alcohol (Ray et al., 2010b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Subjective response to alcohol represents a marker of alcoholism risk. The A118G single-nucleotide polymorphism (SNP) of the mu opioid receptor (OPRM1) gene has been associated with subjective response to alcohol. Recently, the dopamine transporter (DAT1) variable number of tandem repeat (VNTR; SLC6A3) has been found to interact with the OPRM1 A118G SNP in predicting neural and behavioral responses to naltrexone and to alcohol. This exploratory study examines the OPRM1 × DAT1 interaction on subjective responses to alcohol. Non-treatment-seeking problem drinkers (n = 295) were assessed in the laboratory for alcohol dependence. Following prospective genotyping for the OPRM1 gene, 43 alcohol-dependent individuals were randomized to two intravenous infusion sessions, one of alcohol (target BrAC = 0.06 g/dl) and one of saline. Measures of subjective responses to alcohol were administered in both infusion sessions. Analyses revealed significant Alcohol × OPRM1 × DAT1 interactions for alcohol-induced stimulation, vigor and positive mood as well as significant Alcohol × OPRM1 × DAT1 × Time interactions for stimulation and positive mood. These effects were such that, compared with other genotype groups, OPRM1 G-allele carriers + DAT1 A10 homozygotes reported steeper increases in stimulation and positive mood across rising BrAC, when compared with placebo. All Alcohol × OPRM1 × DAT1 interactions remained significant when analyses were restricted to a subsample of Caucasian participants (n = 34); however, 4-way interactions did not reach statistical significance in this subsample. This study suggests that the contribution of OPRM1 genotype to alcohol-induced stimulation, vigor and positive mood is moderated by DAT1 genotype. These findings are consistent with the purported interaction between opioidergic and dopaminergic systems in determining the reinforcing properties of alcohol.
    Alcohol and Alcoholism 01/2014; 49(3). DOI:10.1093/alcalc/agt183 · 2.09 Impact Factor
  • Source
    • "Consistent with our previous work, the target BrACs were 0.02, 0.04, and 0.06 g/dl (Ray and Hutchison, 2004). Previous research has shown that the large subjective effects assessed during intravenous alcohol administration map closely to the subjective effects from oral alcohol consumption at these levels (Ray et al., 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The abbreviated Desires for Alcohol Questionnaire (DAQ) is a self-report assessment of craving comprising the following subscales: (a) strong desires/intentions to drink, (b) negative reinforcement, and (c) positive reinforcement and ability to control drinking. Although the DAQ is sensitive to changes in alcohol craving precipitated by alcohol administration and/or cue exposure, no studies to date have examined the relationship between DAQ scores and subjective responses to alcohol. This study addresses this gap in the literature by testing the relationship between subjective responses to alcohol during alcohol administration and DAQ scores assessed 1 month later. Method: Individuals with alcohol dependence (n = 32) completed a randomized, single-blinded, intravenous alcohol administration in the laboratory in which subjective responses to the alcohol were measured, followed by a visit to the laboratory 1 month later to complete the DAQ. Results: Analyses revealed robust associations between DAQ scores and alcohol craving during alcohol administration (partial correlations: r = .43-.50, ps < .01), with the exception of the positive reinforcement subscale (r = .20, p = .30). Subjective intoxication and sedation were only associated with the negative reinforcement subscale of the DAQ (r = .38, p < .05 and r = .33, p < .05, respectively). Conclusions: Craving, captured by the DAQ, is reliably and positively associated with alcohol-induced craving. The DAQ is also associated with specific dimensions of subjective responses to alcohol. These results support the clinical utility of the DAQ, particularly in large samples where experimental manipulations may not be feasible. (J. Stud. Alcohol Drugs, 74, 797-802, 2013).
    Journal of studies on alcohol and drugs 09/2013; 74(5):797-802. DOI:10.15288/jsad.2013.74.797 · 2.27 Impact Factor
Show more

Preview

Download
3 Downloads
Available from